SAN FRANCISCO--(BUSINESS WIRE)--VIA Pharmaceuticals (NASDAQ: VIAP) a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, today announced that Lawrence Cohen PhD, chief executive officer of VIA, will present a company update at the 2007 BIO Investor Forum in San Francisco on Thursday October 11, 2007 at 12:30 p.m. PDT. Dr. Cohen will also participate in a panel discussion of “Future Treatment Options in Cardiovascular Medicine” at 3:30 p.m. that will be moderated by Michael King, Jr. of Rodman & Renshaw.
